Table 3 Comparative analysis of adverse outcomes in neonates across groups.

From: Association of low shunt burden from PDA and adverse outcomes in premature infants

 

No PDA Burden (n = 69)

Low PDA Burden (n = 43)

p value

Primary outcome

 Death or adverse respiratory outcome

33 (48)

15 (35)

0.239

Respiratory outcomes

 Grade 3 bronchopulmonary dysplasia

2 (3)

1 (2)

1.000

 Chronic pulmonary hypertension

4 (6)

0 (0)

0.296

 Pneumothorax

2 (3)

0 (0)

0.523

 Pulmonary hemorrhage

2 (3)

0 (0)

0.523

 Duration of intubation (days)

17.5 [2, 38]

7 [3, 21]

0.152

 Discharged on oxygen

34 (49)

19 (44)

0.559

Neonatal outcomes

 Death

0 (0)

0 (0)

1.000

 IVH on day 7

13 (19)

4 (9)

0.278

 Severe IVH (Grade 3 or 4)

9 (13)

0 (0)

0.012

 NEC stage 2 or greater

3 (4)

1 (2)

1.000

 Intestinal perforation

1 (1)

0 (0)

1.000

 Severe ROP requiring avastin treatment

1 (1)

0 (0)

1.000

 Systemic hypertension

3 (4)

0 (0)

0.284

 Length of stay (days)

99.9 ± 61.8

82.6 ± 28.6

0.09

  1. Data are presented as frequency (%), median [IQR], or mean ± SD.
  2. IVH intraventricular hemorrhage, NEC necrotizing enterocolitis, PDA patent ductus arteriosus, ROP retinopathy of prematurity.
  3. Bolded p-values are those that are statistically significant.